Turn Therapeutics: Funding, Investors & Team (Oct 2026)
Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics was founded to reduce antibiotic resistance through best-in-class acute and chronic wound care products. The company's mission is to leverage expertise in drug delivery to create disruptive products for high need indications. GLOBAL HEALTH SOLUTIONS, INC. , dba Turn Therapeutics.
Turn Therapeutics has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in Mar 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Turn Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Turn Therapeutics Funding Rounds
Turn Therapeutics Founders and Leadership Team
Contact details for the Turn Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Turn Therapeutics Funding Compared to Other Biotechnology Startups
Turn Therapeutics' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Turn Therapeutics in Biotechnology and Calabasas
Companies Similar to Turn Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Turn Therapeutics Funding FAQs
What does Turn Therapeutics do?
Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics was founded to reduce antibiotic resistance through best-in-class acute and chronic wound care products. The company's mission is to leverage expertise in drug delivery to create disruptive products for high need indications. GLOBAL HEALTH SOLUTIONS, INC. , dba Turn Therapeutics.
How much funding has Turn Therapeutics raised?
Turn Therapeutics has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in Mar 2026.
When did Turn Therapeutics last raise funding?
Turn Therapeutics' most recent funding round on record is an undisclosed round of $7.0M, announced in Mar 2026.
Who founded Turn Therapeutics?
FundedIQ lists Bradley Burnam (Founder) at Turn Therapeutics.
Where is Turn Therapeutics headquartered?
Turn Therapeutics is based in Calabasas, California, United States.
How many employees does Turn Therapeutics have?
Turn Therapeutics is in the 11-50 employee band.
How does Turn Therapeutics' funding compare to other Biotechnology startups?
Turn Therapeutics' latest round of $7.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Turn Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Turn Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.